scispace - formally typeset
R

Richard A. Kroczek

Researcher at Robert Koch Institute

Publications -  85
Citations -  12417

Richard A. Kroczek is an academic researcher from Robert Koch Institute. The author has contributed to research in topics: T cell & Cytotoxic T cell. The author has an hindex of 48, co-authored 85 publications receiving 11788 citations.

Papers
More filters
Journal ArticleDOI

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

TL;DR: In this paper, platelets express CD40L within seconds of activation in vitro and in the process of thrombus formation in vivo, indicating that platelets are not only involved in haemostasis but that they also directly initiate an inflammatory response of the vessel wall.
Journal ArticleDOI

ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

TL;DR: The identification of a third member of this family of molecules, inducible co-stimulator (ICOS), which is a homodimeric protein of relative molecular mass 55,000–60,000 (Mr 55K–60K) indicates that ICOS is another major regulator of the adaptive immune system.
Journal ArticleDOI

Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM

TL;DR: Evidence is presented that point mutations in the TRAP gene give rise to nonfunctional or defective expression of TRAP on the surface of T cells in patients with HIGM1, which is responsible for the observed immunoglobulin isotype defect in HIGm1.
Journal ArticleDOI

Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency

TL;DR: The phenotype of human ICOS deficiency, which differs in key aspects from that of the ICOS−/− mouse, suggests a critical involvement of ICOS in T cell help for late B cell differentiation, class-switching and memory B cell generation.
Journal ArticleDOI

The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40

TL;DR: The findings indicate that the interaction of platelet CD154 with CD40 on neighboring cells is temporally limited to prevent an uncontrolled inflammation at the site of thrombus formation.